Your browser doesn't support javascript.
loading
Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer.
Shen, Mo; Qi, Rongbin; Ren, Justin; Lv, Dongqing; Yang, Haihua.
Afiliação
  • Shen M; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Affiliated Taizhou Hospital of Wenzhou Medical University, Taizhou, China.
  • Qi R; The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
  • Ren J; Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Affiliated Taizhou Hospital of Wenzhou Medical University, Taizhou, China.
  • Lv D; Department of Respiratory Medicine, Enze Hospital, Affiliated Taizhou Hospital of Wenzhou Medical University, Taizhou, China.
  • Yang H; Biological Sciences, Northwestern University, Evanston, Evanston, IL, United States.
Front Oncol ; 11: 780655, 2021.
Article em En | MEDLINE | ID: mdl-35070984
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China